Related Experiment Video
Updated: Jun 30, 2026
09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Intra-nanoparticle Drug-protein Interactions Mediate Sequential Therapeutic Release
Biorxiv : the Preprint Server for Biology
|June 29, 2026
Summary
This study introduces a novel method for controlled drug delivery using human serum albumin nanoparticles. Vancomycin modulates the release of other drugs, enabling simultaneous delivery and predictable release kinetics.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Pharmacology
Background:
- Controlled drug delivery systems aim to improve therapeutic efficacy and minimize side effects.
- Challenges exist in achieving targeted delivery and controlled release rates, leading to off-target accumulation.
- Human serum albumin (HSA)-based nanoparticles offer potential for drug delivery applications.
Purpose of the Study:
- To develop a novel strategy for simultaneous multiple drug encapsulation and controlled release.
- To investigate the modulation of drug release kinetics using a small molecule modulator within HSA nanoparticles.
- To explore the mechanism underlying drug release modulation based on albumin's secondary structure.
Main Methods:
- Fabrication of human serum albumin (HSA)-based nanoparticles for drug encapsulation.
- Incorporation of multiple drugs, including vancomycin, sulfasalazine, and epidermal growth factor.
- In vitro assessment of drug release kinetics in aqueous conditions, modulated by vancomycin.
- Mechanistic investigation of drug-HSA interactions and their effect on albumin secondary structure.
Main Results:
- Demonstrated successful encapsulation and simultaneous release of multiple drugs from HSA nanoparticles.
- Showcased vancomycin's ability to modulate the release rates of other encapsulated drugs (e.g., sulfasalazine, epidermal growth factor) without external stimuli.
- Identified a correlation between drug release kinetics and alterations in the secondary structure of albumin.
- Achieved predictable and sustained drug release profiles through drug-induced structural modulation.
Conclusions:
- A novel water-soluble drug modulation strategy was developed for controlled release from HSA nanoparticles.
- This approach enables simultaneous delivery of multiple therapeutics with predictable release kinetics.
- The findings offer a promising platform for advanced drug delivery systems with enhanced therapeutic outcomes.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:20Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...